1-145912175-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PVS1_ModeratePM2
The NM_003846.3(PEX11B):c.766C>T(p.Arg256*) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000249 in 1,604,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000025 ( 0 hom. )
Consequence
PEX11B
NM_003846.3 stop_gained
NM_003846.3 stop_gained
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 3.75
Genes affected
PEX11B (HGNC:8853): (peroxisomal biogenesis factor 11 beta) The protein encoded by this gene facilitates peroxisomal proliferation and interacts with PEX19. The encoded protein is found in the peroxisomal membrane. Several transcript variants, some protein-coding and some not protein-coding, have been found for this gene. [provided by RefSeq, Dec 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.0179 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEX11B | NM_003846.3 | c.766C>T | p.Arg256* | stop_gained | 4/4 | ENST00000369306.8 | NP_003837.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEX11B | ENST00000369306.8 | c.766C>T | p.Arg256* | stop_gained | 4/4 | 1 | NM_003846.3 | ENSP00000358312.3 | ||
PEX11B | ENST00000537888.1 | c.724C>T | p.Arg242* | stop_gained | 4/4 | 2 | ENSP00000437510.1 | |||
PEX11B | ENST00000428634.1 | c.232C>T | p.Arg78* | stop_gained | 1/2 | 2 | ENSP00000414018.1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152064Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
152064
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000659 AC: 16AN: 242614Hom.: 0 AF XY: 0.0000840 AC XY: 11AN XY: 131006
GnomAD3 exomes
AF:
AC:
16
AN:
242614
Hom.:
AF XY:
AC XY:
11
AN XY:
131006
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000248 AC: 36AN: 1452524Hom.: 0 Cov.: 31 AF XY: 0.0000277 AC XY: 20AN XY: 722030
GnomAD4 exome
AF:
AC:
36
AN:
1452524
Hom.:
Cov.:
31
AF XY:
AC XY:
20
AN XY:
722030
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152064Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74270
GnomAD4 genome
AF:
AC:
4
AN:
152064
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74270
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 08, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 15, 2022 | This sequence change creates a premature translational stop signal (p.Arg256*) in the PEX11B gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 4 amino acid(s) of the PEX11B protein. This variant is present in population databases (rs782188850, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PEX11B-related conditions. ClinVar contains an entry for this variant (Variation ID: 596341). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Peroxisome biogenesis disorder 14B Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Payam Genetics Center, General Welfare Department of North Khorasan Province | Mar 01, 2023 | This sequence change creates a premature translational stop signal (p.Arg256*) in the PEX11B gene. It is expected to disrupt the last 4 amino acid(s) of the PEX11B protein. This variant is present in population databases (rs782188850, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with PEX11B-related conditions and Iranom. The 14 years old boy whit mild intellectual disability and vision problem has been detected whit homozygous c.766C>T mutation on his PEX11B gene and the parents are first cousin. Therefore, it has been classified as a Variant of Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
Vest4
0.56, 0.33
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at